Skip to Content

Health

NIH director says J&J vaccine pause will give researchers time to do more study on certain groups

The pause on the Johnson & Johnson Covid-19 vaccine will allow researchers to investigate a potential link to severe blood clotting events, particularly whether certain types of people are more susceptible, National Institutes of Health Director Dr. Francis Collins said Wednesday. The Centers for Disease Control and Prevention and FDA recommended a pause on use

Continue Reading

CDC advisers will meet today about the J&J Covid-19 vaccine. Here’s what experts and state leaders say about the pause

Advisers to the Centers for Disease Control and Prevention will meet Wednesday to review blood clot cases among people who received the Johnson & Johnson Covid-19 vaccine. The CDC and the US Food and Drug Administration a day earlier recommended the US pause the use of the single-shot J&J vaccine after “six reported US cases

Continue Reading

Reduce risk of severe Covid with regular activity, study says. Here’s how to get in 22 minutes of exercise daily

A history of being consistently active is strongly associated with a reduced risk of severe Covid-19, according to a new study released Tuesday. The Kaiser Permanente study, published in the British Journal of Sports Medicine, looked at nearly 50,000 adults with Covid-19. The research found that those who met the target of the US Department

Continue Reading

How the US hit its vaccine stride

With an average of 3.1 million doses of Covid-19 vaccine administered each day, the United States is on pace to hit another vaccination milestone: Half of adults in the country are expected to have received at least one dose of the vaccine by the end of this week. This signals remarkable progress especially if you

Continue Reading